Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvin Wong

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Elife|April 3, 2020
Functionally heterogeneous human satellite cells identified by single cell RNA sequencingEmilie Barruet, Steven M Garcia, Katharine Striedinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2012
Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomibZhengping Wang, Jinfu Yang, Christopher Kirk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
A phase I single-agent study of twice-weekly consecutive-day dosing of the proteasome inhibitor carfilzomib in patients with relapsed or refractory multiple myeloma or lymphomaMelissa Alsina, Suzanne Trudel, Richard R Furman, et al.
Radiology and Oncology|December 12, 2022
Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective studyBalamurugan Vellayappan, Dennis Cheong, Salil Singbal, et al.
Plos One|February 27, 2015
Aberrant lymphatic endothelial progenitors in lymphatic malformation developmentJune K Wu, Christopher Kitajewski, Maia Reiley, et al.
Acta Dermato-Venereologica|March 31, 2011
Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosaNoor Almaani, Lu Liu, Patricia J C Dopping-Hepenstal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 2, 2022
Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group ReportMoreno Perugini, Tricia J Johnson, Tania Maria Beume, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 9, 2012
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myelomaSundar Jagannath, Ravi Vij, A Keith Stewart, et al.
Lung Cancer (Amsterdam, Netherlands)|June 17, 2020
Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centreGloria Hj Chan, Yong Xiang Gwee, Jia Li Low, et al.
Cancers|April 30, 2021
Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors-Navigating the Radiologic PotpourriAlvin Wong, Balamurugan Vellayappan, Lenith Cheng, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Elife|April 3, 2020
Functionally heterogeneous human satellite cells identified by single cell RNA sequencingEmilie Barruet, Steven M Garcia, Katharine Striedinger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2012
Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomibZhengping Wang, Jinfu Yang, Christopher Kirk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2012
A phase I single-agent study of twice-weekly consecutive-day dosing of the proteasome inhibitor carfilzomib in patients with relapsed or refractory multiple myeloma or lymphomaMelissa Alsina, Suzanne Trudel, Richard R Furman, et al.
Radiology and Oncology|December 12, 2022
Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective studyBalamurugan Vellayappan, Dennis Cheong, Salil Singbal, et al.
Plos One|February 27, 2015
Aberrant lymphatic endothelial progenitors in lymphatic malformation developmentJune K Wu, Christopher Kitajewski, Maia Reiley, et al.
Acta Dermato-Venereologica|March 31, 2011
Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosaNoor Almaani, Lu Liu, Patricia J C Dopping-Hepenstal, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 2, 2022
Are We Ready for a New Approach to Comparing Coverage and Reimbursement Policies for Medical Nutrition in Key Markets: An ISPOR Special Interest Group ReportMoreno Perugini, Tricia J Johnson, Tania Maria Beume, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 9, 2012
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myelomaSundar Jagannath, Ravi Vij, A Keith Stewart, et al.
Lung Cancer (Amsterdam, Netherlands)|June 17, 2020
Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centreGloria Hj Chan, Yong Xiang Gwee, Jia Li Low, et al.
Cancers|April 30, 2021
Atypical Response Patterns in Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors-Navigating the Radiologic PotpourriAlvin Wong, Balamurugan Vellayappan, Lenith Cheng, et al.
Pageof 9